Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

NCT05321810 · clinicaltrials.gov ↗

COMPLETED

Status

193565

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-valvular Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Warfarin

Sponsor

Pfizer